2014-2022年冰岛流感疫苗有效性:检测阴性设计研究
研究采用检测阴性设计,利用2014至2022年国家登记数据评估冰岛七个流感季节的流感疫苗有效性(IVE)。共确诊流感病例2929例,其中儿童781例、60岁以上1192例,甲型H3N2最常见。总体IVE为28.1%(95%CI:20.2-35.3),儿童为61.1%(95%CI:40.6-74.5),成人27.0%(95%CI:18.5-34.6),60岁及以上14.8%(95%CI:1.4-26.3)。IVE在2015-16季最高、2016-17季最低,作者认为提高幼儿疫苗覆盖率可能是预防疾病和传播的有效方式。
要点
- 总体流感疫苗有效性为28.1%(95%CI:20.2-35.3)。
- 儿童疫苗有效性为61.1%(95%CI:40.6-74.5),高于成人27.0%和60岁及以上14.8%。
- 疫苗有效性随季节变化,2015-16季最高、2016-17季最低,可能与疫苗株不匹配有关。
核心结论
- 冰岛流感疫苗有效性随季节变化,儿童中较高,作者认为提高幼儿疫苗覆盖率可能是预防疾病和传播的有效方式。
研究设计与样本
- 采用检测阴性设计,研究人群为每个流感季节第40周至次年第20周接受流感检测的所有个体,数据来自2014至2022年国家登记,分析除2020-21季(未检出流感病例)外的所有研究季节,疫苗有效性按(1-OR)×100%计算并纳入年龄组分类。
主要发现
- 确诊流感病例2929例,其中儿童781例、60岁以上患者1192例,甲型H3N2最常见。
- 总体疫苗有效性为28.1%(95%CI:20.2-35.3)。
- 儿童疫苗有效性为61.1%(95%CI:40.6-74.5),所有成人为27.0%(95%CI:18.5-34.6),60岁及以上为14.8%(95%CI:1.4-26.3)。
- 疫苗有效性在2015-16季最高、2016-17季最低。
临床怎么用
- 作者认为提高幼儿疫苗覆盖率可能是预防疾病和传播的有效方式。
局限性
- 疫苗有效性随季节变化,可能至少部分由于疫苗株不匹配。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Annual influenza epidemics cause heavy disease burden, particularly in children and frail individuals. One of the available preventive measures is vaccination although the vaccine effectiveness is inconsistent. The aim of this study was to evaluate the effectiveness of influenza vaccination (IVE) in Iceland during seven influenza seasons. METHODS: The study population consisted of all individuals tested for influenza during each season from week 40 to week 20 of the following year and data was collected from 2014 to 2022 using national registries. A test-negative design was used to estimate vaccine effectiveness, calculated as (1 - OR) × 100 %, where OR is the odds ratio of vaccination in test-positive cases relative to test-negative controls, including age group classification. Analysis was done for all studied influenza seasons apart from 2020 to 21 when no influenza cases were detected. RESULTS: Confirmed influenza cases were 2929 of which 781 were in children and 1192 in patients older than 60 years. Influenza A, H3N2 was most common. The overall vaccine effectiveness (IVE) was 28.1 % (95 % CI: 20.2-35.3). For children, the VE was 61.1 % (95 % CI:40.6-74.5), for all adults 27.0 % (95 % CI: 18.5-34.6), and for people aged 60 years and older, 14.8 % (95 % CI 1.4-26.3). The IVE was highest in the 2015-16 season and lowest in 2016-17. DISCUSSION: Influenza epidemics in Iceland are similar to other neighbouring countries and infections are common in children. VE varies between seasons, probably at least partly due to vaccine strain mismatch. Despite low VE in several seasons, it can be assumed that thousands of influenza cases were averted. Targeting high vaccine coverage in young children may be an effective way of preventing disease and transmission.
引用
- Thors V, Vias RD, Björnsdóttir K, et al. Influenza vaccine effectiveness in Iceland 2014-2022: A test-negative design. Vaccine. 2025. PMID: 40112556. doi:10.1016/j.vaccine.2025.126981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。